1
|
Karsenty G and Wagner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
2
|
Prockop DJ: Marrow stromal cells as stem
cells for nonhematopoietic tissues. Science. 276:71–74. 1997.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
4
|
Docheva D, Popov C, Mutschler W and
Schieker M: Human mesenchymal stem cells in contact with their
environment: surface characteristics and the integrin system. J
Cell Mol Med. 11:21–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Baksh D, Song L and Tuan RS: Adult
mesenchymal stem cells: characterization, differentiation, and
application in cell and gene therapy. J Cell Mol Med. 8:301–316.
2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kassem M, Abdallah BM and Saeed H:
Osteoblastic cells: differentiation and trans-differentiation. Arch
Biochem Biophys. 473:183–187. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Jones E and Yang X: Mesenchymal stem cells
and bone regeneration: current status. Injury. 42:562–568. 2011.
View Article : Google Scholar
|
8
|
Proff P and Römer P: The molecular
mechanism behind bone remodelling: a review. Clin Oral Investig.
13:355–362. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lazar-Karsten P, Dorn I, Meyer G, et al:
The influence of extracellular matrix proteins and mesenchymal stem
cells on erythropoietic cell maturation. Vox Sang. 101:65–76. 2011.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Vidane AS, Zomer HD, Oliveira BM, et al:
Reproductive stem cell differentiation: extracellular matrix,
tissue microenvironment, and growth factors direct the mesenchymal
stem cell lineage commitment. Reprod Sci. 20:1137–1143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Chen BY, Wang X, Chen LW and Luo ZJ:
Molecular targeting regulation of proliferation and differentiation
of the bone marrow-derived mesenchymal stem cells or mesenchymal
stromal cells. Curr Drug Targets. 13:561–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Soleymaninejadian E, Pramanik K and
Samadian E: Immunomodulatory properties of mesenchymal stem cells:
cytokines and factors. Am J Reprod Immunol. 67:1–8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Chau JF, Leong WF and Li B: Signaling
pathways governing osteoblast proliferation, differentiation and
function. Histol Histopathol. 24:1593–1606. 2009.PubMed/NCBI
|
14
|
Pountos I, Georgouli T, Henshaw K, et al:
The effect of bone morphogenetic protein-2, bone morphogenetic
protein-7, parathyroid hormone, and platelet-derived growth factor
on the proliferation and osteogenic differentiation of mesenchymal
stem cells derived from osteoporotic bone. J Orthop Trauma.
24:552–556. 2010. View Article : Google Scholar
|
15
|
Bonewald LF and Mundy GR: Role of
transforming growth factor-beta in bone remodeling. Clin Orthop
Relat Res. 250:261–276. 1990.PubMed/NCBI
|
16
|
Bonewald LF and Dallas SL: Role of active
and latent transforming growth factor beta in bone formation. J
Cell Biochem. 55:350–357. 1994. View Article : Google Scholar : PubMed/NCBI
|
17
|
Tang Y, Wu X, Lei W, et al:
TGF-beta1-induced migration of bone mesenchymal stem cells couples
bone resorption with formation. Nat Med. 15:757–765. 2009.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
He S, Liu X, Yang Y, et al: Mechanisms of
transforming growth factor beta (1)/Smad signalling mediated by
mitogen-activated protein kinase pathways in keloid fibroblasts. Br
J Dermatol. 162:538–546. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chen G, Deng C and Li YP: TGF-β and BMP
signaling in osteoblast differentiation and bone formation. Int J
Biol Sci. 8:272–288. 2012.
|
21
|
Mbalaviele G, Abu-Amer Y, Meng A, et al:
Activation of peroxisome proliferator-activated receptor-gamma
pathway inhibits osteoclast differentiation. J Biol Chem.
275:14388–14393. 2000. View Article : Google Scholar
|
22
|
Chaudhary LR and Avioli LV: Identification
and activation of mitogen-activated protein (MAP) kinase in normal
human osteoblastic and bone marrow stromal cells: attenuation of
MAP kinase activation by cAMP, parathyroid hormone and forskolin.
Mol Cell Biochem. 178:59–68. 1998. View Article : Google Scholar
|
23
|
Hu Y, Chan E, Wang SX and Li B: Activation
of p38 mitogen-activated protein kinase is required for osteoblast
differentiation. Endocrinology. 144:2068–2074. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Einhorn TA and Trippel SB: Growth factor
treatment of fractures. Instr Course Lect. 46:483–486.
1997.PubMed/NCBI
|
25
|
Hart CE, Bailey M, Curtis DA, et al:
Purification of PDGF-AB and PDGF-BB from human platelet extracts
and identification of all three PDGF dimers in human platelets.
Biochemistry. 29:166–172. 1990. View Article : Google Scholar : PubMed/NCBI
|
26
|
Hollinger JO, Hart CE, Hirsch SN, et al:
Recombinant human platelet-derived growth factor: biology and
clinical applications. J Bone Joint Surg Am. 90:48–54. 2008.
View Article : Google Scholar
|
27
|
Jayakumar A, Rajababu P, Rohini S, et al:
Multi-centre, randomized clinical trial on the efficacy and safety
of recombinant human platelet-derived growth factor with
β-tricalcium phosphate in human intra-osseous periodontal defects.
J Clin Periodontol. 38:163–172. 2011.PubMed/NCBI
|
28
|
Ridgway HK, Mellonig JT and Cochran DL:
Human histologic and clinical evaluation of recombinant human
platelet-derived growth factor and beta-tricalcium phosphate for
the treatment of periodontal intraosseous defects. Int J
Periodontics Restorative Dent. 28:171–179. 2008.
|
29
|
Nevins M, Giannobile WV, McGuire MK, et
al: Platelet-derived growth factor stimulates bone fill and rate of
attachment level gain: results of a large multicenter randomized
controlled trial. J Periodontol. 76:2205–2215. 2005. View Article : Google Scholar
|
30
|
McGuire MK, Kao RT, Nevins M and Lynch SE:
rhPDGF-BB promotes healing of periodontal defects: 24-month
clinical and radiographic observations. Int J Periodontics
Restorative Dent. 26:223–231. 2006.PubMed/NCBI
|
31
|
Distler JH, Hirth A, Kurowska-Stolarska M,
et al: Angiogenic and angiostatic factors in the molecular control
of angiogenesis. Q J Nucl Med. 47:149–161. 2003.PubMed/NCBI
|
32
|
Bouletreau PJ, Warren SM, Spector JA, et
al: Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression
in microvascular endothelial cells: implications for fracture
healing. Plast Reconstr Surg. 109:2384–2397. 2002. View Article : Google Scholar : PubMed/NCBI
|
33
|
Blanquaert F, Pereira RC and Canalis E:
Cortisol inhibits hepatocyte growth factor/scatter factor
expression and induces c-met transcripts in osteoblasts. Am J
Physiol Endocrinol Metab. 278:E509–E515. 2000.PubMed/NCBI
|
34
|
Franchimont N, Durant D, Rydziel S and
Canalis E: Platelet-derived growth factor induces interleukin-6
transcription in osteoblasts through the activator protein-1
complex and activating transcription factor-2. J Biol Chem.
274:6783–6789. 1999. View Article : Google Scholar : PubMed/NCBI
|
35
|
Carano RA and Filvaroff EH: Angiogenesis
and bone repair. Drug Discov Today. 8:980–989. 2003. View Article : Google Scholar : PubMed/NCBI
|
36
|
Andrae J, Gallini R and Betsholtz C: Role
of platelet-derived growth factors in physiology and medicine.
Genes Dev. 22:1276–1312. 2008. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wu E, Palmer N, Tian Z, et al:
Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR
genetically defined cells. PLoS One. 3:e37942008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Missbach M, Jeschke M, Feyen J, et al: A
novel inhibitor of the tyrosine kinase Src suppresses
phosphorylation of its major cellular substrates and reduces bone
resorption in vitro and in rodent models in vivo. Bone. 24:437–449.
1999. View Article : Google Scholar : PubMed/NCBI
|
39
|
Martelli AM, Borgatti P, Bortul R, et al:
Phosphatidylinositol 3-kinase translocates to the nucleus of
osteoblast-like MC3T3-E1 cells in response to insulin-like growth
factor I and platelet-derived growth factor but not to the
proapoptotic cytokine tumor necrosis factor alpha. J Bone Miner
Res. 15:1716–1730. 2000. View Article : Google Scholar
|
40
|
Chaudhary LR and Hruska KA: The cell
survival signal Akt is differentially activated by PDGF-BB, EGF,
and FGF-2 in osteoblastic cells. J Cell Biochem. 81:304–311. 2001.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Antoniades HN: PDGF: a multifunctional
growth factor. Baillieres Clin Endocrinol Metab. 5:595–613. 1991.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Zhou B, Hao Y, Wang C, et al: Conversion
of natively unstructured α-synuclein to its α-helical conformation
significantly attenuates production of reactive oxygen species. J
Inorg Biochem. 118:68–73. 2013.
|
43
|
Mori T, Kiyono T, Imabayashi H, et al:
Combination of hTERT and bmi-1, E6, or E7 induces prolongation of
the life span of bone marrow stromal cells from an elderly donor
without affecting their neurogenic potential. Mol Cell Biol.
25:5183–5195. 2005. View Article : Google Scholar : PubMed/NCBI
|
44
|
Shimomura T, Yoshida Y, Sakabe T, et al:
Hepatic differentiation of human bone marrow-derived UE7T-13 cells:
effects of cytokines and CCN family gene expression. Hepatol Res.
37:1068–1079. 2007. View Article : Google Scholar : PubMed/NCBI
|
45
|
Huang H, Hu ZZ, Arighi CN and Wu CH:
Integration of bioinformatics resources for functional analysis of
gene expression and proteomic data. Front Biosci. 12:5071–5088.
2007.PubMed/NCBI
|
46
|
Dalle Carbonare L, Innamorati G and
Valenti MT: Transcription factor Runx2 and its application to bone
tissue engineering. Stem Cell Rev. 8:891–897. 2012.PubMed/NCBI
|
47
|
Neve A, Corrado A and Cantatore FP:
Osteoblast physiology in normal and pathological conditions. Cell
Tissue Res. 343:289–302. 2011. View Article : Google Scholar : PubMed/NCBI
|
48
|
Gharibi B, Ghuman MS and Hughes FJ: Akt-
and Erk-mediated regulation of proliferation and differentiation
during PDGFRβ-induced MSC self-renewal. J Cell Mol Med.
16:2789–2801. 2012.PubMed/NCBI
|
49
|
Chen JF, Mandel EM, Thomson JM, et al: The
role of microRNA-1 and microRNA-133 in skeletal muscle
proliferation and differentiation. Nat Genet. 38:228–233. 2006.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Conti L, Sipione S, Magrassi L, et al: Shc
signaling in differentiating neural progenitor cells. Nat Neurosci.
4:579–586. 2001. View
Article : Google Scholar : PubMed/NCBI
|
51
|
Dugan LL, Kim JS, Zhang Y, et al:
Differential effects of cAMP in neurons and astrocytes. Role of
B-raf. J Biol Chem. 274:25842–25848. 1999. View Article : Google Scholar : PubMed/NCBI
|
52
|
Sottile V, Halleux C, Bassilana F, et al:
Stem cell characteristics of human trabecular bone-derived cells.
Bone. 30:699–704. 2002. View Article : Google Scholar : PubMed/NCBI
|
53
|
Pereira RC, Delany AM and Canalis E:
Effects of cortisol and bone morphogenetic protein-2 on stromal
cell differentiation: correlation with CCAAT-enhancer binding
protein expression. Bone. 30:685–691. 2002. View Article : Google Scholar
|
54
|
Lecka-Czernik B, Moerman EJ, Grant DF, et
al: Divergent effects of selective peroxisome
proliferator-activated receptor-gamma 2 ligands on adipocyte versus
osteoblast differentiation. Endocrinology. 143:2376–2384. 2002.
|
55
|
Janssens K, ten Dijke P, Janssens S and
Van Hul W: Transforming growth factor-beta1 to the bone. Endocr
Rev. 26:743–774. 2005. View Article : Google Scholar : PubMed/NCBI
|
56
|
Lee JY, Kim KH, Shin, et al: Enhanced bone
formation by transforming growth factor-beta1-releasing
collagen/chitosan microgranules. J Biomed Mater Res A. 76:530–539.
2006. View Article : Google Scholar : PubMed/NCBI
|
57
|
Zhao L, Jiang S and Hantash BM:
Transforming growth factor beta1 induces osteogenic differentiation
of murine bone marrow stromal cells. Tissue Eng Part A. 16:725–733.
2010. View Article : Google Scholar : PubMed/NCBI
|
58
|
Lee KS, Hong SH and Bae SC: Both the Smad
and p38 MAPK pathways play a crucial role in Runx2 expression
following induction by transforming growth factor-beta and bone
morphogenetic protein. Oncogene. 21:7156–7163. 2002. View Article : Google Scholar : PubMed/NCBI
|
59
|
Ripamonti U, Ferretti C, Teare J and Blann
L: Transforming growth factor-beta isoforms and the induction of
bone formation: implications for reconstructive craniofacial
surgery. J Craniofac Surg. 20:1544–1555. 2009. View Article : Google Scholar : PubMed/NCBI
|
60
|
Quarles LD, Yohay DA, Lever LW, et al:
Distinct proliferative and differentiated stages of murine MC3T3-E1
cells in culture: an in vitro model of osteoblast development. J
Bone Miner Res. 7:683–692. 1992. View Article : Google Scholar : PubMed/NCBI
|
61
|
Luo X, Chen J, Song WX, et al: Osteogenic
BMPs promote tumor growth of human osteosarcomas that harbor
differentiation defects. Lab Invest. 88:1264–1277. 2008. View Article : Google Scholar : PubMed/NCBI
|
62
|
Chen J, Shapiro HS and Sodek J:
Development expression of bone sialoprotein mRNA in rat mineralized
connective tissues. J Bone Miner Res. 7:987–997. 1992. View Article : Google Scholar : PubMed/NCBI
|
63
|
Fisher LW, McBride OW, Termine JD and
Young MF: Human bone sialoprotein: deduced protein sequence and
chromosomal localization. J Biol Chem. 265:2347–2351.
1990.PubMed/NCBI
|
64
|
Ganss B, Kim RH and Sodek J: Bone
sialoprotein. Crit Rev Oral Biol Med. 10:79–98. 1999. View Article : Google Scholar : PubMed/NCBI
|
65
|
Ogata Y: Bone sialoprotein and its
transcriptional regulatory mechanism. J Periodontal Res.
43:127–135. 2008. View Article : Google Scholar : PubMed/NCBI
|
66
|
Bianco P, Fisher LW, Young MF, et al:
Expression of bone sialoprotein (BSP) in developing human tissues.
Calcif Tissue Int. 49:421–426. 1991. View Article : Google Scholar : PubMed/NCBI
|
67
|
Chosa N, Taira M, Saitoh S, et al:
Characterization of apatite formed on alkaline-heat-treated Ti. J
Dent Res. 83:465–469. 2004. View Article : Google Scholar : PubMed/NCBI
|
68
|
Id Boufker H, Lagneaux L, Fayyad-Kazan H,
et al: Role of farnesoid X receptor (FXR) in the process of
differentiation of bone marrow stromal cells into osteoblasts.
Bone. 49:1219–1231. 2011.PubMed/NCBI
|